Cdn Warrant News

TRxADE GROUP, INC. Announces Uplisting to Nasdaq Capital Market, Pricing of $5.2 Million Firm Commitment Public Offering of Common Stock and Effectiveness of Reverse Stock Split – GlobeNewswire

TRxADE GROUP, INC. Announces Uplisting to Nasdaq Capital Market, Pricing of $5.2 Million Firm Commitment Public Offering of Common Stock and Effectiveness of Reverse Stock Split GlobeNewswire

TRxADE GROUP, INC. Announces Uplisting to Nasdaq Capital Market, Pricing of $5.2 Million Firm Commitment Public Offering of Common Stock and Effectiveness of Reverse Stock Split – GlobeNewswire Read More »

Armata Pharmaceuticals Announces Closing of First Tranche of Recently Executed $25 Million Securities Purchase Agreement with Innoviva, Inc. – GuruFocus.com

Armata Pharmaceuticals Announces Closing of First Tranche of Recently Executed $25 Million Securities Purchase Agreement with Innoviva, Inc. GuruFocus.com

Armata Pharmaceuticals Announces Closing of First Tranche of Recently Executed $25 Million Securities Purchase Agreement with Innoviva, Inc. – GuruFocus.com Read More »

Scroll to Top